CX3CR1 and Alzheimer disease: In human and 5xFAD mice frontal cortical samples, microglial CX3CR1 expression was increased in advanced AD, with CX3CR1 mRNA significantly upregulated at intermediate and advanced stages, indicating CX3CR1 as a potential therapeutic target in disease progression (González-Prieto et al., 2021).